Advanced search
Publication Cover
Future Medicinal Chemistry Volume 2, 2010 - Issue 5
Submit an article Journal homepage
189
Views
0
CrossRef citations to date
0
Altmetric
Review

Natural Products and Ion Channel Pharmacology

Russell W Teichert1 University of Utah, Department of Biology, 257 South 1400 East, Salt Lake City, Utah84112, USAView further author information
&
Baldomero M Olivera1 University of Utah, Department of Biology, 257 South 1400 East, Salt Lake City, Utah84112, USACorrespondence[email protected]
View further author information
Pages 731-744 | Published online: 12 May 2010

Bibliography

  • Cuatrecasas P . Drug discovery in jeopardy.J. Clin. Investig.116(11), 2837–2842 (2006).
  • Kola I , LandisJ. Can the pharmaceutical industry reduce attrition rates?Nat. Rev. Drug Discov.3(8), 711–715 (2004).
  • Munos B . Lessons from 60 years of pharmaceutical innovation.Nat. Rev. Drug Discov.8(12), 959–968 (2009).
  • PhRMA . Pharmaceutical industry profile 2009. America, PRaMo, PhRMA, Washington, DC, USA (2009).
  • Hirschler B . Drugmakers face $140 billion patent ‘Cliff’. In: Reuters.London, UK (2007)
  • Hopkins AL . Network pharmacology: the next paradigm in drug discovery.Nat. Chem. Biol.4(11), 682–690 (2008).
  • Molinari G . Natural products in drug discovery: present status and perspectives.Adv. Exp. Med. Biol.655, 13–27 (2009).
  • Newman DJ . Natural products as leads to potential drugs: an old process or the new hope for drug discovery?J. Med. Chem.51(9), 2589–2599 (2008).
  • Newman DJ , CraggGM. Natural products as sources of new drugs over the last 25 years.J. Nat. Prod.70(3), 461–477 (2007).
  • Newman DJ , CraggGM, SnaderKM. Natural products as sources of new drugs over the period 1981–2002.J. Nat. Prod.66, 1022–1037 (2003).
  • Gorse AD . Diversity in medicinal chemistry space.Curr. Top. Med. Chem.6(1), 3–18 (2006).
  • Bohacek RS , McMartinC, GuidaWC. The art and practice of structure-based drug design: a molecular modeling perspective.Med. Res. Rev.16(1), 3–50 (1996).
  • Koehn FE , CarterGT. The evolving role of natural products in drug discovery.Nat. Rev. Drug Discov.4(3), 206–220 (2005).
  • Li JW , VederasJC. Drug discovery and natural products: end of an era or an endless frontier?Science325(5937), 161–165 (2009).
  • Soejarto DD , FongHH, TanGTet al. Ethnobotany/ethnopharmacology and mass bioprospecting: issues on intellectual property and benefit-sharing. J. Ethnopharmacol. 100(1–2), 15–22 (2005).
  • Chang CC , LeeCY. Isolation of neurotoxins from the venom of bungarus multicinctus and their modes of neuromuscular blocking action. Arch. Int. Pharmacodyn. Ther.144, 241–257 (1963).
  • Biass D , DutertreS, GerbaultAet al. Comparative proteomic study of the venom of the piscivorous cone snail conus consors. J. Proteomics 72(2), 210–218 (2009).
  • Escoubas P , KingGF. Venomics as a drug discovery platform.Expert Rev. Proteomics6(3), 221–224 (2009).
  • Escoubas P , SollodB, KingGF. Venom landscapes: mining the complexity of spider venoms via a combined cDNA and mass spectrometric approach.Toxicon47(6), 650–663 (2006).
  • Corpuz GP , JacobsenRB, JimenezECet al. Definition of the M-conotoxin superfamily: characterization of novel peptides from Molluscivorous conus venoms. Biochemistry 44(22), 8176–8186 (2005).
  • Espiritu DJD , WatkinsM, Dia-MonjeV, CartierGE, CruzLJ, OliveraBM. Venomous cone snails: molecular phylogeny and the generation of toxin diversity.Toxicon.39, 1899–1916 (2001).
  • Olivera BM , TeichertRW. Diversity of the neurotoxic conus peptides: a model for concerted pharmacological discovery.Mol. Intervent.7(5), 251–260 (2007).
  • Santos AD , McIntoshJM, HillyardDR, CruzLJ, OliveraBM. The α-superfamily of conotoxins: structural and functional divergence.J. Biol. Chem.279, 17596–17606 (2004).
  • Escoubas P , QuintonL, NicholsonGM. Venomics: unravelling the complexity of animal venoms with mass spectrometry.J. Mass Spectrom.43(3), 279–295 (2008).
  • Ueberheide BM , FenyoD, AlewoodPF, ChaitBT. Rapid sensitive analysis of cysteine rich peptide venom components.Proc. Natl Acad. Sci. USA106(17), 6910–6915 (2009).
  • Miljanich GP . Ziconotide: neuronal calcium channel blocker for treating severe chronic pain.Curr. Med. Chem.11, 3029–3040 (2004).
  • Prommer E . Ziconotide: a new option for refractory pain.Drugs Today (Barc), 42(6), 369–378 (2006).
  • Olivera BM , CruzLJ, de Santos V et al. Neuronal Ca channel antagonists. Discrimination between Ca channel subtypes using ω-conotoxin fromconus magus venom. Biochemistry26, 2086–2090 (1987).
  • Olivera BM , GrayWR, ZeikusRet al. Peptide neurotoxins from fish-hunting cone snails. Science 230, 1338–1343 (1985).
  • Olivera BM , MiljanichG, RamachandranJ, AdamsME. Calcium channel diversity and neurotransmitter release: the ω-conotoxins and ω-agatoxins.Annu. Rev. Biochem.63, 823–867 (1994).
  • Yoshikami D , BagabaldoZ, OliveraBM. The inhibitory effects of ω-conotoxins on calcium channels and synapses.Ann. NY Acad. Sci.560, 230–248 (1989).
  • Cahalan MD , ChandyKG. The functional network of ion channels in t lymphocytes.Immunol. Rev.231(1), 59–87 (2009).
  • Rangaraju S , ChiV, PenningtonMW, ChandyKG. Kv1.3 potassium channels as a therapeutic target in multiple sclerosis. Expert Opin. Ther. Targets, 13(8), 909–924 (2009).
  • Pennington MW , ByrnesME, ZaydenbergIet al. Chemical synthesis and characterization of shk toxin: a potent potassium channel inhibitor from a sea anemone. Int. J. Pept. Protein Res. 46(5), 354–358 (1995).
  • Castañeda O , SotolongoV, AmorAMet al. Characterization of a potassium channel toxin from the caribbean sea anemone Stichodactyla helianthus. Toxicon 33, 603–613 (1995).
  • Wulff H , CalabresiPA, AllieRet al. The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS. J. Clin. Invest. 111(11), 1703–1713 (2003).
  • Kalman K , PenningtonMW, LaniganMDet al. Shk-dap22, a potent Kv1.3-specific immunosuppressive polypeptide. J. Biol. Chem. 273(49), 32697–32707 (1998).
  • Beeton C , WulffH, BarbariaJet al. Selective blockade of t lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc. Natl Acad. Sci. USA 98(24), 13942–13947 (2001).
  • Pennington MW , BeetonC, GaleaCAet al. Engineering a stable and selective peptide blocker of the Kv1.3 channel in t lymphocytes. Mol. Pharmacol. 75(4), 762–773 (2009).
  • Press Release . Kineta acquires novel drug candidates from airmid for potential treatment of multiple sclerosis, Type 1 diabetes and other autoimmune diseases. Kineta, Inc., Seattle, Washington, USA, July2009.
  • Fusetani N , KemW. Marine toxins: an overview.Prog. Mol. Subcell Biol.46, 1–44 (2009).
  • Nakao Y , FusetaniN. Enzyme inhibitors from marine invertebrates.J. Nat. Prod.70(4), 689–710 (2007).
  • Röckel D , KornW, KohnAJ. Manual of the living conidae. Verlag Christa Hemmen, Wiesbaden, Germany (1995).
  • Duda J r TE, Palumbi SR. Gene expression and feeding ecology: evolution of piscivory in the venomous gastropod genus conus. Proc. Royal Soc. London271, 1165–1174 (2004).
  • Imperial J , SilvertonN, OliveraBMet al. Using chemistry to reconstruct evolution: on the origins of fish-hunting in venomous cone snails. Proc. Am. Phil. Soc. 151, 185–200 (2007).
  • Olivera BM . Conus venom peptides, receptor and ion channel targets and drug design: 50 million years of neuropharmacology. Mol. Biol. Cell8, 2101–2109 (1997).
  • Olivera BM , CruzLJ. Conotoxins, in retrospect.Toxicon39, 7–14 (2001).
  • Terlau H , ShonK, GrilleyM, StockerM, StühmerW, OliveraBM. Strategy for rapid immobilization of prey by a fish-hunting cone snail.Nature381, 148–151 (1996).
  • Hillyard DR , MonjeVD, MintzIMet al. A new conus peptide ligand for mammalian presynaptic Ca2+ channels. Neuron 9, 69–77 (1992).
  • Twede VD , MiljanichG, OliveraBM, BulajG. Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads.Curr. Opin. Drug Discov. Devel.12(2), 231–239 (2009).
  • Sato K , IshidaY, WakamatsuKet al. Active site µ-conotoxin giiia, a peptide blocker of muscle sodium channels. J. Biol. Chem. 266, 16989–16991 (1991).
  • Barbier J , LamthanhH, Le Gall F et al. A δ-conotoxin from conus ermineus venom inhibits inactivation in vertebrate neuronal Na+ channels but not in skeletal and cardiac muscles. J. Biol. Chem.279, 4680–4685 (2004).
  • McIntosh JM , CruzLJ, HunkapillerMW, GrayWR, OliveraBM. Isolation and structure of a peptide toxin from the marine snail conus magus. Arch. Biochem. Biophys.218, 329–334 (1982).
  • Hopkins C , GrilleyM, MillerCet al. A new family of conus peptides targeted to the nicotinic acetylcholine receptor. J. Biol. Chem. 270, 22361–22367 (1995).
  • Zafaralla GC , RamiloC, GrayWR, KarlstromR, OliveraBM, CruzLJ. Phylogenetic specificity of cholinergic ligands: A-conotoxin s1.Biochemistry27, 7102–7105 (1988).
  • Myers RA , ZafarallaGC, GrayWR, AbbottJ, CruzLJ, OliveraBM. α-Conotoxins, small peptide probes of nicotinic acetylcholine receptors.Biochemistry30, 9370–9377 (1991).
  • Ramilo CA , ZafarallaGC, NadasdiLet al. Novel α- and ω-conotoxins from conus striatus venom. Biochemistry 31, 9919–9926 (1992).
  • Jacobsen R , YoshikamiD, EllisonMet al. Differential targeting of nicotinic acetylcholine receptors by novel α-conotoxins. J. Biol. Chem. 272, 22531–22537 (1997).
  • Shon K , KoerberSC, RivierJE, OliveraBM, McIntoshJM. Three-dimensional solution structure of α-conotoxin mii, an a3b2 neuronal nicotinic acetylcholine receptor-targeted ligand.Biochemistry36, 15693–15700 (1997).
  • Zhang MM , FiedlerB, GreenBRet al. Structural and functional diversities among mu-conotoxins targeting ttx-resistant sodium channels. Biochemistry 45(11), 3723–3732 (2006).
  • Shon K , OliveraBM, WatkinsMet al. µ-conotoxin piiia, a new peptide for discriminating among tetrodotoxin-sensitive Na channel subtypes. J. Neurosci. 18, 4473–4481 (1998).
  • Bulaj G , WestPJ, GarrettJEet al. Novel conotoxins from conus striatus and conus kinoshitai selectively block ttx-resistant sodium channels. Biochemistry 44, 7259–7265 (2005).
  • Leipold E , HanselA, OliveraBM, TerlauH, HeinemannSH. Synergistic voltage sensor trapping of sodium channels by d-conotoxins and scorpion a-toxins.FEBS Lett. (2005) (In Press).
  • Shon K , GrilleyMM, MarshMet al. Purification, characterization and cloning of the lockjaw peptide from conus purpurascens venom. Biochemistry 34, 4913–4918 (1995).
  • Bayrhuber M , VijayanV, FerberMet al. Conkunitzin-S1 is the first member of a new kunitz-type neurotoxin family. Structural and functional characterization. J. Biol. Chem. 280(25), 23766–23770 (2005).
  • Walker CS , JensenS, EllisonMet al. A novel conus snail polypeptide causes excitotoxicity by blocking desensitization of AMPA receptors. Curr. Biol. 19, 1–9 (2009).
  • Groebe DR , DummJM, LevitanES, AbramsonSN. α-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors.Mol. Pharmacol.48, 105–111 (1995).
  • Terlau H , OliveraBM. Conus venoms: a rich source of novel ion channel-targeted peptides. Physiol. Rev.84, 41–68 (2004).
  • Adams DJ , SmithAB, SchroederCI, YasudaT, LewisRJ. ω-conotoxin CVID inhibits a pharmacologically distinct voltage-sensitive calcium channel associated with transmitter release from preganglionic nerve terminals (PDB ID. 1TTK).J. Biol. Chem.278, 4057–4062 (2003).
  • Tudor JE , PallaghyPK, PenningtonMW, NortonRS. Solution structure of Shk toxin, a novel potassium channel inhibitor from a sea anemone (PDB ID. 1ROO).Nat. Struct. Biol.3, 317–320 (1996).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.